A Single Infusion Could Suppress H.I.V. for Years, Study Suggests
The New York Times • • health
Key Points:
- Scientists have successfully used modified immune cells to cure some blood cancers and are now applying a similar approach to control HIV, with promising early results reported in a new study.
- Two participants in the study achieved undetectable HIV levels after a single infusion of engineered immune cells, with one maintaining suppression for nearly two years.
- The findings, presented at a gene therapy conference, provide "proof of concept" that a one-time treatment could potentially offer lifelong HIV control.
- Experts in the field, including Dr. Steve Deeks and Dr. Hans-Peter Kiem, have praised the study as an inspiring milestone and a significant step forward in HIV treatment research.
- Although the treatment is still years or decades away from widespread availability, the study offers hope for a future where HIV can be effectively managed with a single therapeutic intervention.